U.S. Physical Therapy (NYSE:USPH) Shares Pass Above 200 Day Moving Average of $95.00

U.S. Physical Therapy, Inc. (NYSE:USPH)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $95.00 and traded as high as $98.38. U.S. Physical Therapy shares last traded at $97.60, with a volume of 60,739 shares traded.

Analyst Ratings Changes

Several research firms have recently issued reports on USPH. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 13th. Finally, Barrington Research lifted their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $125.67.

U.S. Physical Therapy Trading Down 0.5 %

The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28. The company has a market capitalization of $1.47 billion, a price-to-earnings ratio of 72.30, a price-to-earnings-growth ratio of 4.71 and a beta of 1.39. The business’s 50 day simple moving average is $104.50 and its 200 day simple moving average is $95.00.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. The company had revenue of $154.80 million for the quarter, compared to analyst estimates of $150.24 million. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. U.S. Physical Therapy’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.58 earnings per share. Research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were paid a $0.44 dividend. The ex-dividend date of this dividend was Monday, March 11th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 dividend on an annualized basis and a yield of 1.80%. U.S. Physical Therapy’s payout ratio is currently 130.37%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, insider Eric Joseph Williams sold 1,500 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.96, for a total value of $157,440.00. Following the sale, the insider now owns 19,314 shares of the company’s stock, valued at $2,027,197.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider Eric Joseph Williams sold 1,500 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.96, for a total value of $157,440.00. Following the sale, the insider now owns 19,314 shares of the company’s stock, valued at $2,027,197.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Carey P. Hendrickson sold 1,800 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares in the company, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,829 shares of company stock worth $1,141,535. 1.80% of the stock is owned by company insiders.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors have recently added to or reduced their stakes in USPH. Northwest Bank & Trust Co purchased a new stake in U.S. Physical Therapy during the fourth quarter worth about $37,000. SRS Capital Advisors Inc. lifted its holdings in shares of U.S. Physical Therapy by 308.0% in the fourth quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock valued at $38,000 after purchasing an additional 308 shares in the last quarter. Lazard Asset Management LLC lifted its holdings in shares of U.S. Physical Therapy by 754.7% in the first quarter. Lazard Asset Management LLC now owns 453 shares of the company’s stock valued at $45,000 after purchasing an additional 400 shares in the last quarter. Quantbot Technologies LP purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $82,000. Finally, Captrust Financial Advisors lifted its holdings in shares of U.S. Physical Therapy by 348.9% in the first quarter. Captrust Financial Advisors now owns 844 shares of the company’s stock valued at $84,000 after purchasing an additional 656 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.